Accuri Cytometers, Inc., a life sciences company marketing and producing bench-top flow cytometer systems, and eBioscience, the number two supplier of research flow cytometry reagents, announced that they have entered into a worldwide co-marketing agreement.
The Cell Lab Signaling Cytometry (Cell Lab SC) line of reagents from Beckman Coulter, Inc., offers a comprehensive set of antibodies for the detection of the phosphorylation state of signaling proteins in cells via flow cytometry.
Regulatory compliance experts GxPi announce the availability of its leading Electronic Document Management System (eDMS) x-docs as a hosted software service.
Intellipharmaceutics International Inc., announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR (venlafaxine hydrochloride).
Asthma and other allergic diseases are caused by inappropriate immune responses. Soluble IgE molecules, produced by immune cells known as B cells, are key immune mediators of these diseases.
Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers.
A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.
The cause of tuberculosis is Mycobacterium tuberculosis (Mtb), a slow-growing aerobic bacterium that divides every 16 to 20 hours.
Inducing cellular immunity as a means to protect against influenza virus is the focus of several laboratories at the Trudeau Institute.
Merck & Co. said it settled a patent dispute with Glenmark Pharmaceuticals on the cholesterol drug Zetia, one of its best-selling products.
Gilead Sciences, Inc. announced that the company's board of directors has authorized the repurchase of up to $5 billion of the company's common stock through May 2013.
Abbott Laboratories will license at least 24 products in emerging markets through a new unit created to boost sales outside of the U.S., the drug and medical device maker said.
Drugmaker Merck & Co. said that its integration of Schering Plough Corp. is off to a good start, with sales and other operations already combined in the top 20 companies where they operate.
IntelliCyt Corp., a provider of innovative high throughput cell and bead-based screening products for drug discovery and life science research, introduced its new High Throughput Flow Cytometry – HTFC Screening System.
In a bid to meet growing international demand for its liquid handling quality assurance products and services, Artel is expanding into Germany, Switzerland, and Austria, where it will begin offering direct sales and distribution of its Multichannel Verification System and Pipette Calibration System.